Home LiteratureArticle Details
PMID: 18806225 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Inflammation and autoimmunity caused by a SHP1 mutation depend on IL-1, MyD88, and a microbial trigger.

Croker BA, Lawson BR, Rutschmann S, Berger M, Eidenschenk C, Blasius AL, Moresco EM, Sovath S, Cengia L, Shultz LD, Theofilopoulos AN, Pettersson S, Beutler BA

Abstract

A recessive phenotype called spin (spontaneous inflammation) was induced by N-ethyl-N-nitrosourea (ENU) mutagenesis in C57BL/6J mice. Homozygotes display chronic inflammatory lesions affecting the feet, salivary glands and lungs, and antichromatin antibodies. They are immunocompetent and show enhanced resistance to infection by Listeria monocytogenes. TLR-induced TNF and IL-1 production are normal in macrophages derived from spin mice. The autoinflammatory phenotype of spin mice is fully suppressed by compound homozygosity for Myd88(poc), Irak4(otiose), and Il1r1-null mutations, but not Ticam1(Lps2), Stat1(m1Btlr), or Tnf-null mutations. Both autoimmune and autoinflammatory phenotypes are suppressed when spin homozygotes are derived into a germ-free environment. The spin phenotype was ascribed to a viable hypomorphic allele of Ptpn6, which encodes the tyrosine phosphatase SHP1, mutated in mice with the classical motheaten alleles me and me-v. Inflammation and autoimmunity caused by SHP1 deficiency are thus conditional. The SHP1-deficient phenotype is driven by microbes, which activate TLR signaling pathways to elicit IL-1 production. IL-1 signaling via MyD88 elicits inflammatory disease.

MeSH Terms
Alleles Animals Autoimmune Diseases/genetics,immunology,microbiology Autoimmunity/genetics Ethylnitrosourea/pharmacology Homozygote Inflammation/genetics,immunology,microbiology Interleukin-1/genetics,immunology Interleukin-1 Receptor-Associated Kinases/genetics,immunology Listeriosis/immunology Mice Mice, Mutant Strains Mutagenesis Mutation Myeloid Differentiation Factor 88/genetics,immunology Protein Tyrosine Phosphatase, Non-Receptor Type 6/genetics Receptors, Interleukin-1/immunology Toll-Like Receptors/immunology
Chemicals
Interleukin-1 Myeloid Differentiation Factor 88 Receptors, Interleukin-1 Toll-Like Receptors Interleukin-1 Receptor-Associated Kinases Irak4 protein, mouse Protein Tyrosine Phosphatase, Non-Receptor Type 6 Ptpn6 protein, mouse Ethylnitrosourea
Authors & Affiliations
13 authors, click to expand affiliations / ORCID
Croker Ben A
Department of Genetics, The Scripps Research Institute, 10550 N. Torrey Pines Road, La Jolla, CA 92037, USA.
Lawson Brian R
Rutschmann Sophie
Berger Michael
Eidenschenk Celine
Blasius Amanda L
Moresco Eva Marie Y
Sovath Sosathya
Cengia Louise
Shultz Leonard D
Theofilopoulos Argyrios N
Pettersson Sven
Beutler Bruce Alan
References (35)
35 references, click to expand
  1. Treatment of murine lupus with cDNA encoding IFN-gammaR/Fc.
    J Clin Invest. 2000 Jul;106(2):207-15 PMID: 10903336
  2. Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain.
    Cell. 2000 Oct 13;103(2):351-61 PMID: 11057907
  3. Crystal structure of human protein-tyrosine phosphatase SHP-1.
    J Biol Chem. 2003 Feb 21;278(8):6516-20 PMID: 12482860
  4. The pivotal role of interleukin-1 in the clinical manifestations of rheumatoid arthritis.
    Rheumatology (Oxford). 2003 May;42 Suppl 2:ii3-10 PMID: 12817089
  5. The 'Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling.
    Trends Biochem Sci. 2003 Jun;28(6):284-93 PMID: 12826400
  6. Identification of Lps2 as a key transducer of MyD88-independent TIR signalling.
    Nature. 2003 Aug 14;424(6950):743-8 PMID: 12872135
  7. Lps2: a new locus required for responses to lipopolysaccharide, revealed by germline mutagenesis and phenotypic screening.
    J Endotoxin Res. 2003;9(4):250-5 PMID: 12935356
  8. Activated Ets2 is required for persistent inflammatory responses in the motheaten viable model.
    J Immunol. 2004 Jul 15;173(2):1374-9 PMID: 15240733
  9. An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder.
    Blood. 2004 Aug 1;104(3):735-43 PMID: 15069016
  10. Motheaten, an immunodeficient mutant of the mouse. I. Genetics and pathology.
    J Hered. 1975 Sep-Oct;66(5):250-8 PMID: 1184950
  11. Motheaten, an immunodeficient mutant of the mouse. II. Depressed immune competence and elevated serum immunoglobulins.
    J Immunol. 1976 Apr;116(4):936-43 PMID: 56406
  12. Motheater: an immunodeficient mouse with markedly less ability to survive that the nude mouse in a germfree environment.
    J Immunol. 1976 May;116(5):1496-7 PMID: 1270804
  13. "Viable motheaten," a new allele at the motheaten locus. I. Pathology.
    Am J Pathol. 1984 Aug;116(2):179-92 PMID: 6380298
  14. Pleiotropic effects of deleterious alleles at the "motheaten" locus.
    Curr Top Microbiol Immunol. 1988;137:216-22 PMID: 3416633
  15. SH2 domains recognize specific phosphopeptide sequences.
    Cell. 1993 Mar 12;72(5):767-78 PMID: 7680959
  16. Mutations at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (Hcph) gene.
    Cell. 1993 Jul 2;73(7):1445-54 PMID: 8324828
  17. Motheaten and viable motheaten mice have mutations in the haematopoietic cell phosphatase gene.
    Nat Genet. 1993 Jun;4(2):124-9 PMID: 8348149
  18. Expression and catalytic activity of the tyrosine phosphatase PTP1C is severely impaired in motheaten and viable motheaten mice.
    J Exp Med. 1993 Dec 1;178(6):2157-63 PMID: 8245788
  19. Crystal structures of peptide complexes of the amino-terminal SH2 domain of the Syp tyrosine phosphatase.
    Structure. 1994 May 15;2(5):423-38 PMID: 7521735
  20. Differential regulation of the alpha/beta interferon-stimulated Jak/Stat pathway by the SH2 domain-containing tyrosine phosphatase SHPTP1.
    Mol Cell Biol. 1995 Dec;15(12):7050-8 PMID: 8524272
  21. Differential functions of the two Src homology 2 domains in protein tyrosine phosphatase SH-PTP1.
    Proc Natl Acad Sci U S A. 1996 Feb 6;93(3):1141-5 PMID: 8577729
  22. B and T cells are not required for the viable motheaten phenotype.
    J Exp Med. 1996 Feb 1;183(2):371-80 PMID: 8627150
  23. Role of cytokines in rheumatoid arthritis.
    Annu Rev Immunol. 1996;14:397-440 PMID: 8717520
  24. Role of tumor necrosis factor-alpha in the spontaneous development of pulmonary fibrosis in viable motheaten mutant mice.
    Am J Pathol. 1997 Nov;151(5):1303-10 PMID: 9358756
  25. Reduction of arthritis and pneumonitis in motheaten mice by soluble tumor necrosis factor receptor.
    Arthritis Rheum. 1998 Jan;41(1):139-49 PMID: 9433879
  26. Revealing mechanisms for SH2 domain mediated regulation of the protein tyrosine phosphatase SHP-2.
    Structure. 1998 Mar 15;6(3):249-54 PMID: 9551546
  27. Functional consequences of the SHP-1 defect in motheaten viable mice: role of NF-kappa B.
    Cell Immunol. 1998 Apr 10;185(1):49-58 PMID: 9636682
  28. PanR1, a dominant negative missense allele of the gene encoding TNF-alpha (Tnf), does not impair lymphoid development.
    J Immunol. 2006 Jun 15;176(12):7525-32 PMID: 16751399
  29. Details of Toll-like receptor:adapter interaction revealed by germ-line mutagenesis.
    Proc Natl Acad Sci U S A. 2006 Jul 18;103(29):10961-6 PMID: 16832055
  30. Toll-like receptors in systemic autoimmune disease.
    Nat Rev Immunol. 2006 Nov;6(11):823-35 PMID: 17063184
  31. Jinx, an MCMV susceptibility phenotype caused by disruption of Unc13d: a mouse model of type 3 familial hemophagocytic lymphohistiocytosis.
    J Exp Med. 2007 Apr 16;204(4):853-63 PMID: 17420270
  32. TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity.
    Nat Med. 2007 May;13(5):543-51 PMID: 17479100
  33. B cell-specific deletion of protein-tyrosine phosphatase Shp1 promotes B-1a cell development and causes systemic autoimmunity.
    Immunity. 2007 Jul;27(1):35-48 PMID: 17600736
  34. Cryopyrin-associated periodic syndromes and autoinflammation.
    Clin Exp Dermatol. 2008 Jan;33(1):1-9 PMID: 17927785
  35. Phosphatase SHP-1 promotes TLR- and RIG-I-activated production of type I interferon by inhibiting the kinase IRAK1.
    Nat Immunol. 2008 May;9(5):542-50 PMID: 18391954
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
1091-6490
Published
2008-09-30
Epub
2008-00-19
Pages
15028-33
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC2567487
Subset
IM
Grants
NIGMS NIH HHS · GM067759 · United States
PHS HHS · HHSN272200700038C · United States
NIGMS NIH HHS · R01 GM067759 · United States
NIGMS NIH HHS · R37 GM067759 · United States
NIAID NIH HHS · HHSN272200700038C · United States
NCI NIH HHS · CA31496 · United States
Corrections
ErratumIn
-
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com